The COVID-19 vaccine developed by China’s Sinovac Biotech is effective against the UK and South African variants, the vaccine’s Brazilian partner said on Wednesday, citing test results in Chinese trials.
“We have tested this vaccine in China against the English and the South African variants, with good results,” said Dimas Covas, head of the Butantan biomedical center in Sao Paulo which lead domestic trials of the Chinese vaccine and is supplying doses to Brazil’s Health Ministry.
Covas did not give any more details on exactly how effective the vaccine proved against these strains.
Butantan is also testing the vaccine, known as CoronaVac, against the Brazilian variant of the virus which appeared in the city of Manaus, he said.
“Soon we will have the results and we are very positive it will do the job,” Covas said.
Covas was speaking at a news conference in the small city of Serrana, in the interior of Sao Paulo state, where Butantan began on Wednesday a mass vaccination campaign aimed at inoculating the entire adult population against COVID-19 to test whether it lowers the infection rate.
Covas said he expects CoronaVac to have an advantage over other vaccines due to the technology it uses – an inactivated version of a coronavirus strain.
The efficacy of the Chinese vaccine against the Brazilian strain in particular will be vital to Brazil. The government has secured 100 million doses and made the vaccine a centerpiece of its inoculation campaign.
Covas’ comments come as several cities in Brazil, including state capitals of Rio, Salvador and Cuiaba have suspended new vaccinations as they ran out of doses.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.